Archive for the ‘Treatment’ Category

Diagnosed with Cellulitis – Child Had Lyme – Docs Said it was a “Non-relevant Tick Bite”

http://www.kcra.com/article/mother-hopes-parents-see-side-effects-of-lyme-disease-after-daughter-suffers-tick-bite/22122176

NEW SALEM, Pa. —
Morgan Rogers, 4, loves to play outside. But recently, she’s been spending more and more time inside, after being bitten by a tick sometime last month.

Watch the video in the above link to see the full story.

For more on the story:  https://madisonarealymesupportgroup.com/2018/07/06/non-relevant-tick-bite-puts-child-in-hospital/

_______________

**Comment**

The medical world baffled yet again.

Treat each and every tick bite as seriously as a heart attack.  Everyone knows prompt treatment makes THE difference, so why do doctors even hesitate?

If you are bitten, follow this advice:  https://iladef.org/education/how-to-handle-a-tick-bite/

ILADS recommends that prophylaxis (preventive treatment) be discussed with all who have had a blacklegged tick bite. An appropriate course of antibiotics has been shown to prevent the onset of infection.

When the decision is made to use antibiotic prophylaxis, ILADS recommends 20 days of doxycycline (provided there are no contraindications). The decision to treat a blacklegged tick bite with antibiotics often depends on where in the country the bite occurred, whether there was evidence that the tick had begun feeding, and the age of the person who was bitten. Based on the available evidence, and provided that it is safe to do so, ILADS recommends a 20-day course of doxycycline.

Patients should also know that although doxycycline can prevent cases of Lyme disease, ticks in some areas carry multiple pathogens, some of which, including Babesia, Powassan virus, and Bartonella, are not responsive to doxycycline. This means a person could contract a tick-borne illness despite receiving antibiotic prophylaxis for their known tick bite.

ILADS recommends against single-dose doxycycline. Some doctors prescribe a single 200 mg dose of doxycycline for a known bite. However, as discussed in detail in the guidelines, this practice is based on a flawed study that has never been replicated. Read more in the ILADS treatment guidelines.

The bottom line: If you have been bitten by a blacklegged tick, you should discuss immediate antibiotic treatment with your provider as a possible course of action.

If you do receive prophylactic treatment, be cautious in in interpreting the results of subsequent testing. Widely-used blood tests look for antibodies to Borrelia burgdorferi, but early treatment can prevent the body from mounting an antibody response. Should you become infected despite prophylactic treatment, subsequent tests results could be falsely negative.

Whether or not you choose to get prophylactic treatment after a tick bite, it is imperative to be vigilant for symptoms that might suggest active infection. Common Lyme symptoms include fever, headache, muscle and joint pain, and fatigue.

Here’s the dealeo – if you want to play Russian roulette and take a chance, that’s your business.  They are now saying that around 50% of ticks in endemic areas are infected, but ticks are spreading into areas they’ve never been “found” before and they are often coinfected with many things.  Lyme is just the tip of the ice-berg.  If you are diligent with probiotics and diet, your body should handle the doxycycline (or whatever antimicrobial used) just fine.  This prompt treatment is a bit like insurance.  Not having insurance is hunky-dory until it’s your house that burns down.  

FYI:  My husband and I have probably paid $150K for the two of us to be treated for Lyme/MSIDS.  That’s a chunk of change and frankly had we been treated with 20 days of doxy, we probably wouldn’t have had to spend it.

For ILADS treatment guidelines:  https://www.tandfonline.com/doi/full/10.1586/14787210.2014.940900

For Lyme Treatments from numerous practitioners:  https://madisonarealymesupportgroup.com/2016/02/13/lyme-disease-treatment/

 

 

 

 

Congenital Transmission of Lyme – Myth or Reality?

https://dermagicexpress.blogspot.com/2018/07/congenital-transmission-of-erythema.html?m=1

July 22, 2018

CONGENITAL TRANSMISSION OF ERYTHEMA MIGRANS OR LYME DISEASE, MYTH OR REALITY ?

AUTHORS

1.) Dr. Lapenta, J Medic Surgeon, Specialty Dermatology, 24 years of exercise. Highly trained in the field of research; University of Carabobo, Venezuela. CEO DERMAGIC EXPRESS. www.dermagicexpress.blogspot.com

2.) Dr. Lapenta, JM. Medic Surgeon. University of Carabobo. Diplomat in Facial Aesthetics Occupational Medicine and Prehospital Auxiliary. Resident Doctor Ambulatorio Del Norte Maracay Aragua State. COO DERMAGIC EXPRESS.  www.dermagicexpress.blogspot.com

ABSTRACT

Lyme disease or Erythema Migrans, described many years ago, and previously known under the name of Lyme Juvenile Arthritis, is produced by a spirochete transmitted by the bite of a family tick. Ixodidade, Ixodes scapularis and many others; discovered by the scientist Willy Burgdorfer in the year of 1981, being named Borrelia Burgorferi, in honor of its discoverer. Apart from the numerous cutaneous and organic manifestations attributed to Borrelia, it is nowadays discussed in the scientific field if it is capable of crossing the placenta and causing fetal damage. In this review we will show you that this biological agent, as in syphilis, produced by Treponema Pallidum, another spirochete, crosses the placenta and can produce serious consequences to the fetus, including death.

Key words: Lyme disease, Borrelia burgdorferi, congenital lyme, fetal damage and pregnancy

MAIN OBJECTIVE

The main objective of this work is to demonstrate that Lyme disease and their biological agent, spirochete Borrelia Burgdorferi, is not only an illness with cutaneous manifestations. It can cross the placenta during pregnancy and produce fetal damage that in severe cases can cause death in newborns.

SECONDARY OBJECTIVES.

1.) Describe the clinical manifestations in children born from positive Lyme mothers who did not receive treatment in pregnancy, or in those who received treatment with resistance to it.

2.) Alert the World community that there is indeed transplacental transmission of Borrelia Burgdorferi in pregnant Lyme positive women and if there is not adequate treated in time, both the mother and fetus can present clinical symptoms ranging from mild, to severe, even stillbirth.

3.) To call attention to the World Health Organization so that in the revision of the international codes of diseases (ICD-11), this year 2018, the code “Congenital Lyme” be  included in them.

INTRODUCTION

The Center for Disease Control and Prevention (CDC) affirms in its website that the pregnant woman Lyme positive when making her treatment, the child will be born healthy and recommends for this, the use of the antibiotic amoxicillin or cefuroxime, because doxycycline, which is the antibiotic of choice, can cause damage to the developing fetus. [1]

Other antibiotics recommended by the CDC are the macrolides azithromycin, clarithromycin or erythromycin in case of allergy or intolerance to those previously mentioned. [2]

The CDC itself recognizes that Lyme disease and its causative agent Borrelia Burgdorferi can cross the placenta and cause stillbirths. [1-2]

The question here is what would happen if the Borrelia species, as in some cases, is resistant to amoxicillin or another antibiotic, or the antibiotic to which Borrelia is sensitive cannot be indicated because it would harm the fetus? And beyond, if the patient does not receive the treatment by omission or carelessness? [3]

As we said previously the Borrelia Burgdorferi was discovered by Willy Burgdorfer in the year 1981, and just two (2) year later, in 1983 the first study was published by Shirts SR, and Brown MS, Bobitt Jr, where it is suspected that this spirochete can cross the placenta. [4]

After this study others began to appear, who definitely showed that this spirochete is able to cross the placenta and cause fetal damage, of which we will present in chronological order the most important and confirm the above said.

CHRONOLOGICAL EVOLUTION

1983

The first suspicion described that ante partum fever may be caused by the Borrelia Burgdorferi species, was made in 1983 in two febrile pregnant women in the third-trimester. The two newborn survived, but the scientists suggested the establishment of early laboratory tests to identify the causative agent and the establishment of a rapid treatment to avoid future complications in the pregnant and the fetus. [4]

1985

Really, the first study describing the maternal-fetal transmission of Lyme disease, Borrelia Burgdorferi was published in 1985 by Schlesinger PA, Duray PH, Burke BA, Steere AC, and Stillman MT., Where they describe a case of a pregnant woman who acquired Lyme Borreliosis and did not receive treatment with antibiotics. The child was born at 35 weeks of pregnancy and died of congenital heart disease the first week of life. The autopsy revealed the Borrelia Burgdorferi spirochete in the spleen, kidneys and bone marrow. [5]

1986-1989

In the year 1986, MacDonald A, describes 4 cases of abortions in pregnant women who tested positive for Lyme, and in whose fetuses the Borrelia Burgdorferi was found in their tissues. This same author does another work in 1989 about Lyme disease and its implications for the fetus and describes side effects such as fetal death, hydrocephalus, cardiovascular abnormalities, neonatal respiratory distress, hyperbilirubinemia, intrauterine growth retardation, cortical blindness, sudden death syndrome of the infant and maternal toxemia of pregnancy, and raises the similarity of these with neonatal syphilis. [6-7].

1987

Later, the same Willy Burgdorfer the discoverer of the Borrelia Burgdorferi, together with Dr. Alan Mc Donald and Jorge Benach PhD, published in year 1987 (31 years ago) a work where they relate this disease with children born dead associated in pregnant Lyme positive.

Among the highlights the description of congenital malformations, fetal death, cardiac anomalies and alert the scientific community to investigate exposure during the first trimester of pregnancy in the presence of Borrelia Burgdorferi; and in this cases to determine if cardiac organogenesis is complete by the end of the first trimester of pregnancy. They also recommend starting treatment with Penicillin at the same dose of syphilis in those cases of pregnant women who show signs and early symptoms of the disease. [8]

1988-2012

In these 24 years a total of more than 80 papers were published where Lyme disease is effectively related to pregnancy with fetal damage, studies done in the countries: United States, Canada, Hungary, Germany, Italy, Switzerland, Africa, Turkey, Czech Republic, Poland and Belgrade former Yugoslavia, and others [10-52]

Another study that is worth noting is that carried out by the updated MEDLINE database for the year of July 2012, the last revision of November 2012 of 88 journal articles from the PUBMED database, which we summarize in this way

Maternal-fetal transmission of Lyme disease (Findings):

1.) Mothers with active Lyme disease, treated: 14.6% of pregnancies resulted in sequel (a morbid condition following or occurring as a consequence of having Lyme).

2.) Mothers with active Lyme disease not treated: 66.7% of pregnancies resulted in sequel.

3.) Positive Lyme mothers, the treatment is unknown: 30.3% resulted in sequel.

4.) Specific adverse results included:

– Cardiac 22.7%,

– Neurological 15.2%,

– Orthopedic 12.1%,

– Ophthalmologic 4.5%,

– Genitourinary 10.6%,

– Miscellaneous anomalies 12.1%. [53]

Now we will put a summary of the most frequent clinical manifestations described in a study of more than 100 children born to mothers with LYME positive disease, conducted in the year 2005.

COMMON SIGNS AND SYMPTOMS IN LYME POSITIVE CHILDREN:

1.) Low grade fever: 59% -60%
2.) Fatigue and lack of resistance: 72%
3.) Nocturnal sweating: 23%
4.) Pale, dark circle under the eyes: 42%
5.) Abdominal pain: 20-29%
6.) Diarrhea or constipation: 32%
7.) Nausea: 23%
8.) Cardiac anomalies: 23%: palpitations / PVC, heart murmur, mitral valve prolapse.
9.) Orthopedic disorders: sensitivity (55%), pain (69%) spasms and generalized muscle pain (69%), rigidity and / or retarded motion (23%).
10.) Respiratory infections of the superior tract and otitis: 40%
11.) Arthritic disorders and painful joints: 6% -50-%
12.) Neurological disorders:
A- Headaches: 50%
B-) Irritability: 54%.
C-) Bad memory: 39%
13.) Delay in development: 18%
14.) Seizure disorder: 11%
15.) Vertigo: 30%
16.) Tic disorders: 14%
17.) Involuntary athetoid movements: 9%.
18.) Earning disorders and humor changes: 80%
A-) Cognitive speaking: 27%
B-) Speech delay: 21%
C-) Reading-writing problems: 19%
D.) Problems of vocal articulation: 17%.
E-) Auditory / visual processing problems: 13%
F-) Word selection problems: 12%
G-) Dyslexia: 8%
19.) Suicidal thoughts: 7%
20.) Anxiety: 21%
21.) Anger or rage: 23%
22.) Aggression or violence: 13%
23.) Irritability: 54% -80%
24.) Emotional disorders: 13%
25.) Depression: 13%
26.) Hyperactivity: 36%
27.) Photophobia: 40-43%
28.) Gastroesophageal reflux with vomiting and coughing: 40%
29.) Secondary eruptions: 23%
30.) Other eruptions: 45%
31.) Cavernous haemangioma: 30%
32.) Ocular problems: posterior cataracts, myopia, stigmatism, conjunctive erythema (Lyme eyes), optical nerve atrophy and / of uveitis: 30%
33.) Sensitivity of skin and noise (hyperacuity): 36-40%
46.) Autism: (9%). [41]

2013-2018

In recent years the number of cases of Lyme disease has increased notably in North America, Europe, Asia and Africa; in the United States and Canada, it is the most commonly transmitted vector-borne disease reported today [54-62].

For the year 2017 the World Health Organization (WHO) in charge of “coding” diseases through the ICD-10 (International Classification of Diseases year 2.017), had not yet included and recognized the code “Congenital Lyme”. It is expected for this year 2018 that all codes of Lyme disease will be recognized by this organization. [63-68]

You can read this classification and codes here:  UNDERSTANDIG THE LYME DISEASE CLASSIFICATION AND CODES. [69]

CONCLUSIONS

1.) Lyme disease is caused by the bite of a tick transmitted by the Borrelia Burgdorferi spirochete, discovered by Willy Burgdorfer in the year 1981. Initially, skin, joint and cardiac manifestations were described in those affected, but not in pregnant women or the fetus.

2.) Two years later, in 1983, was described the suspicion of infection in pregnant women, and in 1985 it was found the first clinical manifestations in pregnant women and fetuses, highlighting congenital malformations and fetal death.

3.) We demonstrate scientifically that definitely Lyme disease, in addition to its multiple organic manifestations, its causative agent Borrelia Burgdorferi, crosses the placenta and reaches the fetus in pregnant women, producing the side effects already described.

4.) All pregnant women living in endemic areas of Lyme disease should take the tests to rule out Borreliosis of pregnancy, to establish immediate treatment in case of being positive.

5.) In addition to establishing adequate treatment, we alert the population to defend against the bite of possibly infected ticks.

6.) We urge the World Health Organization to recognize all the codes and classification of Lyme disease in ICD-11 (International Classification of Diseases year 2.018).

ACKNOWLEDGMENTS

To the community of patients affected by Lyme disease.

To the organizations that fight for the recognition of this pathology as a public health problem World.

__________________

**Comment**

The Lyme community owes a debt of gratitude to the doctors Lapenta.  You will see many of their articles on my website as they have painstakingly combed through the research and condensed it for laypeople to clearly see the ramifications of Lyme and other tick borne illnesses.

This article makes plain that Lyme can be passed congenitally to infants.

For more on pregnancy with Lyme:

https://madisonarealymesupportgroup.com/2018/06/19/33-years-of-documentation-of-maternal-child-transmission-of-lyme-disease-and-congenital-lyme-borreliosis-a-review/

https://madisonarealymesupportgroup.com/2018/02/26/transplacental-transmission-fetal-damage-with-lyme-disease/

https://madisonarealymesupportgroup.com/2018/05/24/new-berlin-mom-given-life-altering-lyme-disease-diagnoses-after-pregnancy/

https://madisonarealymesupportgroup.com/2017/10/15/pregnancy-in-lyme-dr-ann-corson/

 

 

 

2018 ILADS Annual Conference in Chicago

Chicago Banner

Conference Registration Open!

Please join us for the International Lyme and Associated Diseases Society (ILADS) 19th Annual Conference. This year’s conference will be held on November 1-4, 2018, at the Sheraton Grand Chicago in downtown Chicago, IL. ILADS is delighted to meet in the Midwest for the first time.

 

The conference theme is Tick-Borne Diseases and the Immune System.

Thursday, November 1, 2018

  • Lyme Fundamentals
  • Experimental Treatments for Tick-Borne Diseases
  • Social – Theatrical performance about Lyme disease plus a demonstration of Hand Pans with a reception sponsored by IGeneX. Guests of registrants are welcome to attend this event.

ILADS Committee meetings also will be held.

On Thursday evening, November 1, 2018, IGeneX is sponsoring our theater event  featuring A BEAUTIFUL DANCE OF LIFE & DEATH, a true story of surviving Lyme disease.  The play is written by Erin R Hartnett, directed by Nicholas Collett, and performed by Sam Wright and Meredith Lindsay.  A reception follows the performance, which will feature ILADS own Dayna Wolfe, MD, who will be demonstrating Hand Pans to raise funds for ILADEF.  Come by to see what this is all about. Never heard of Hand Pans?  https://www.youtube.com/watch?v=6oremFnbgO0. Tickets are available for yourself and guests; space is limited.

We again are offering the Lyme Fundamentals course for practitioners who want to brush up their clinical skills and for those who are new to treating Lyme disease. This one-day track gives specific step-by-step guidance with ample opportunity to ask questions of the expert faculty. CME credits will be offered for this track. This session is for medical professionals only. There are a limited number of grants available to reimburse the registration fee for first time attending professionals.

We also are offering a day-long track called Experimental Treatments for Tick-Borne Diseases, which will look at promising new treatment options for Lyme patients. (Due to the evolving treatment modalities discussed, no CME will be given for this track.)

The Scientific Conference on Friday, November 2, 2018, through Sunday, November 4, 2018, will include the following:

  • Plenary Sessions – mornings Friday through Sunday
  • Breakout Sessions – Friday and Saturday afternoons
  • Poster Sessions – Friday morning through Sunday morning
  • Pioneer in Lyme Award Dinner – Friday evening social event honoring Kenneth B. Liegner, MD
  • Annual Members’ meeting Saturday late afternoon

The Scientific Conference schedule will extend from Friday morning to Sunday noon. Course Director Mualla McManus, PharmD, and her committee have planned a series of provocative lectures which will help you develop insights on the role of the immune system in the treatment of tick-borne diseases. Highly-regarded researchers and clinicians will share cutting-edge information during the plenary sessions and more topic-specific breakout sessions. CME will be offered for the entire Scientific Conference. We expect this conference to sell out, so please register as soon as possible and book your room at our conference hotel at our conference rate.

Chicago Conference Information:  www.ilads.org/ilads-conference/chicago-2018/
2018 ILADEF Pioneer Award Dinner:  https://customer274405b6f.portal.membersuite.com/events/ViewEvent.aspx?

The Pioneer in Lyme Award dinner (on Friday, November 2nd) will honor the lifetime achievement of Kenneth B. Liegner, MD, a past Board member of ILADS. Dr. Liegner is well known in the medical community for his intellectual vigor and personalized treatment protocols. Please join us for an elegant dinner featuring midwestern-inspired fare. The Jazz Ensemble, AS IS, will also provide entertainment.

rsz_ken2
Kenneth Liegner, MD, is a board-certified Internist with additional training in Pathology and Critical Care Medicine, practicing in Pawling, New York.  He has been actively involved in the diagnosis and treatment of Lyme disease and related disorders since 1988.  He has published articles on Lyme disease in peer-reviewed scientific journals and has presented poster abstracts and talks at national and international conferences on Lyme and other tick-borne diseases.  He has cared for many persons seriously ill with chronic and neurologic Lyme disease.  His work has focused on the serious morbidity and (occasional) mortality that can eventuate from this aspect of the illness.  He has emphasized the urgent need for the widespread clinical availability of improved methods of diagnostic testing and for the development of improved methods of treatment for Lyme disease in all its stages.  He holds the first U.S. patent issued proposing the application of acaricide to deer for area-wide control of deer-tick populations as a means of reducing the incidence of Lyme disease.  ILADEF invites you to join us for this prestigious event where you will have the opportunity to engage with some of the world’s leading Lyme disease researchers and clinicians as we join together to honor Dr. Liegner and address the number one vector-borne epidemic worldwide.

More on Liegner:  https://madisonarealymesupportgroup.com/2017/03/09/remember-vicki-logan/

50+ exhibitors will be on-site from Thursday morning through Sunday noon, showcasing products and services relevant to medical professionals who treat tick-borne diseases.

Exploring the Controversial Concept of Chronic Lyme Disease

 Approx. 4 Min.

Exploring the Controversial Concept of Chronic Lyme Disease

Contagion_Live
Published on Jul 20, 2018

Samuel Shor, MD, FACP, (past ILADS president) explores the controversial concept of chronic Lyme disease and the role of antibiotic stewardship in treatment programs.

To see the controversy in action:

 Approx. 8 Min.
Contagion_Live
Published on Aug 21, 2017

Lyme Disease: Theories for Longer-Term Manifestations

Panelists Peter L. Salgo, MD; Leonard Sigal, MD; Samuel Shor, MD, FACP; Robert C. Bransfield, MD, DLFAPA; and Patricia V. Smith outline potential theories for longer-term clinical manifestations that have a less clear-cut link to Lyme disease

Proof of borrelia persistence:  https://madisonarealymesupportgroup.com/2015/09/19/proof-of-borrelia-persistence/

https://madisonarealymesupportgroup.com/2017/08/18/drexel-prof-lyme-persists/

https://madisonarealymesupportgroup.com/2018/04/17/persistent-borrelia-infection-in-patients-with-ongoing-symptoms-of-lyme-disease/   (More links within article)

http://norvect.no/230-peer-reviewed-studies-show-evidence-of-persistent-lyme-disease/

https://www.ilads.org/wp-content/uploads/2018/07/CLDList-ILADS.pdf

https://madisonarealymesupportgroup.com/2016/08/09/dr-paul-duray-research-fellowship-foundation-some-great-research-being-done-on-lyme-disease/   The work of Dr. Elizabeth Burgess DVM PhD in 1990 showed that dogs infected with LD were transmitting and infecting female dogs through sexual transmission, proof in humans is lacking. Pathologist Alan McDonald found B. burgdorferi and B. mayonii in the testicle and brain of a man who had been treated nearly continuously on antibiotics for the last seven years of his life. Grier states the case for sexual transmission is stronger than ever.

https://madisonarealymesupportgroup.com/2018/06/19/33-years-of-documentation-of-maternal-child-transmission-of-lyme-disease-and-congenital-lyme-borreliosis-a-review/

https://madisonarealymesupportgroup.com/2018/06/28/the-science-isnt-settled-on-chronic-lyme/

This recent study shows dead Lyme debris causes inflammation:

https://madisonarealymesupportgroup.com/2018/07/17/study-shows-dead-lyme-debris-persists-in-cns-despite-antibiotics-and-causes-inflammation/

_______________

Two points for consideration:

  • “The absence of evidence is not the evidence of absence”
  • Would you deny antibiotic treatment to those suffering with chronic tuberculosis, chlamydia, or bladder infections?

Parinaud’s Oculoglandular Syndrome & Bartonella

https://www.ncbi.nlm.nih.gov/m/pubmed/29982178/

Atypical presentation of cat scratch disease: Parinaud’s oculoglandular syndrome with facial nerve paresis.

Valor C, et al. BMJ Case Rep. 2018.

Abstract

A 28-year-old man presented to our clinic over the course of 3 weeks with symptoms that progressed from mild headaches to fever, fatigue, myalgia and an enlarged right preauricular lymph node with ipsilateral (same side) conjunctivitis and upper eyelid weakness. Our differential included Epstein Barr Virus/Cytomegalovirus mononucleosis, bacterial conjunctivitis and lymphoma. We evaluated with CBC, EBV IgM Ab, lactate dehydrogenase level and a CMV IgG Ab which were all within normal limits. During his third visit, we discovered our patient had been scratched by two stray kittens he had adopted 2 months prior. We confirmed the diagnosis with a positive Bartonella henselae IgG level and diagnosed him with cat scratch disease presenting as Parinaud’s oculoglandular syndrome. He was treated with a 5-day course of Azithromycin 250 mg with definitive improvement.

________________

**Comment**

The pre auricular lymph node is #5 in the diagram.  So this is a swollen nodule in front of the ear with conjunctivitis (pink-eye) on the same side as the nodule with upper eye-lid weakness.    

 

Illu_lymph_chain01

Public Domain, https://commons.wikimedia.org/w/index.php?curid=1471974

I would also like to point out it’s on record that people can have Bart without cat-scratch:  https://madisonarealymesupportgroup.com/2018/07/10/bartonella-henselae-neuroretinitis-in-patients-without-cat-scratch/  In conclusion, even though there may be a lack of systemic signs and symptoms of CSD in a patient with neuroretinitis, B henselae infection should be considered. 

While authorities argue about whether ticks transmit Bart or not, please see:  https://www.sciencedirect.com/topics/medicine-and-dentistry/parinauds-oculoglandular-syndrome  Finally, tick-borne B. henselae infection has been described, including scalp eschar and neck lymphadenopathy after tick bites in three patients during the colder months in France. B. henselae was detected using molecular tools both in skin biopsy (cervical and occipital) and in a Dermacentor marginatus tick removed from the scalp of one patient. All three patients had asthenia (weakness), but none had alopecia.

That same Science Direct link above also states that a common ocular manifestation is Parinaud’s oculoglandular syndrome……

I predict we are going to see a lot more on Bartonella in the future and it’s going to blow this whole “atypical” and “rare” thing out of the water.

For more on Bart:  https://madisonarealymesupportgroup.com/2016/01/03/bartonella-treatment/

https://madisonarealymesupportgroup.com/2018/06/12/osteomyelitis-in-cat-scratch-disease-a-never-ending-dilemma-a-case-report-literature-review/

https://madisonarealymesupportgroup.com/2018/05/07/fox-news-bartonella-is-the-new-lyme-disease/

https://madisonarealymesupportgroup.com/2016/08/09/a-bartonella-story/

https://madisonarealymesupportgroup.com/2017/09/13/dr-fox-cat-scratch-fever-warning/